• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

所有药代动力学方程都一样吗?成人金黄色葡萄球菌菌血症住院患者第1天曲线下面积估计的梯形法与非梯形法比较分析

Are All Pharmacokinetic Equations Created Equal? A Comparative Analysis of Trapezoidal and Non-Trapezoidal Methods for Estimating Day 1 Area Under the Curve in Adult Hospitalized Patients with Staphylococcus aureus Bacteremia.

作者信息

Msdi Abdulwhab Shremo, Ravari Alireza Fakhri, Abdul-Mutakabbir Jacinda C, Tan Karen K

机构信息

Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, 77204, USA.

Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA, USA.

出版信息

Infect Dis Ther. 2025 Mar;14(3):615-626. doi: 10.1007/s40121-025-01115-4. Epub 2025 Feb 17.

DOI:10.1007/s40121-025-01115-4
PMID:39962022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11933637/
Abstract

INTRODUCTION

This study compared the calculated vancomycin area under the curve (AUC) using trapezoidal and non-trapezoidal first-order pharmacokinetic equations.

METHODS

This retrospective observational study included adult patients with documented MRSA bacteremia who received ≥ 48 h of intravenous vancomycin and had two consecutive serum levels after the first dose. AUC was calculated using trapezoidal and non-trapezoidal equations. Correlation and agreement between methods were assessed using Pearson's correlation coefficient (r) and Bland-Altman plots. Significant predictors (p < 0.05) from simple linear regression were included in a multiple linear regression model to evaluate their impact on AUC for both methods.

RESULTS

Fifty-two patients were included. The median age was 63 years (interquartile range [IQR]: 50-73), and the median vancomycin clearance was 4 l/h (IQR: 2-6). Median vancomycin AUC was 399 mg∙h/l (IQR: 257-674) for the trapezoidal method and 572 mg∙h/l (IQR: 466-807) for the non-trapezoidal method. There was a strong correlation between the methods (r = 0.87 [95% CI, 0.79-1]; P < 0.01), but Bland-Altman analysis showed poor agreement, with a bias of - 198 mg∙h/l and 95% limits of agreement from - 482 to 86 mg∙h/l. In multiple linear regression, total daily dose and vancomycin clearance were independent predictors of AUC for both methods, with a stronger impact on non-trapezoidal AUC (adjusted R = 0.70) than trapezoidal AUC (adjusted R = 0.59).

CONCLUSIONS

Trapezoidal and non-trapezoidal equations are not interchangeable for estimating vancomycin AUC. The trapezoidal method consistently results in lower AUC estimates than the non-trapezoidal method.

摘要

引言

本研究比较了使用梯形和非梯形一级药代动力学方程计算的万古霉素曲线下面积(AUC)。

方法

这项回顾性观察性研究纳入了有记录的耐甲氧西林金黄色葡萄球菌(MRSA)菌血症成年患者,这些患者接受了≥48小时的静脉万古霉素治疗,且在首剂给药后有连续两次血清浓度。使用梯形和非梯形方程计算AUC。采用Pearson相关系数(r)和Bland-Altman图评估两种方法之间的相关性和一致性。简单线性回归中具有显著意义的预测因素(p<0.05)被纳入多元线性回归模型,以评估它们对两种方法的AUC的影响。

结果

共纳入52例患者。中位年龄为63岁(四分位间距[IQR]:50 - 73),万古霉素清除率中位数为4升/小时(IQR:2 - 6)。梯形法计算的万古霉素AUC中位数为399毫克∙小时/升(IQR:257 - 674),非梯形法为572毫克∙小时/升(IQR:466 - 807)。两种方法之间存在强相关性(r = 0.87 [95% CI,0.79 - 1];P < 0.01),但Bland-Altman分析显示一致性较差,偏差为 - 198毫克∙小时/升,一致性界限为 - 482至86毫克∙小时/升。在多元线性回归中,每日总剂量和万古霉素清除率是两种方法AUC的独立预测因素,对非梯形AUC(调整后R = 0.70)的影响比对梯形AUC(调整后R = 0.59)更强。

结论

梯形和非梯形方程在估算万古霉素AUC时不可互换。梯形法得出的AUC估算值始终低于非梯形法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/c5746da03eb4/40121_2025_1115_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/39336b9dfac1/40121_2025_1115_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/b873c9f11ab1/40121_2025_1115_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/232738ada00b/40121_2025_1115_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/c5746da03eb4/40121_2025_1115_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/39336b9dfac1/40121_2025_1115_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/b873c9f11ab1/40121_2025_1115_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/232738ada00b/40121_2025_1115_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1284/11933637/c5746da03eb4/40121_2025_1115_Fig4_HTML.jpg

相似文献

1
Are All Pharmacokinetic Equations Created Equal? A Comparative Analysis of Trapezoidal and Non-Trapezoidal Methods for Estimating Day 1 Area Under the Curve in Adult Hospitalized Patients with Staphylococcus aureus Bacteremia.所有药代动力学方程都一样吗?成人金黄色葡萄球菌菌血症住院患者第1天曲线下面积估计的梯形法与非梯形法比较分析
Infect Dis Ther. 2025 Mar;14(3):615-626. doi: 10.1007/s40121-025-01115-4. Epub 2025 Feb 17.
2
Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational Study.使用非梯形线性药代动力学方程表征成人住院患者万古霉素负荷剂量给药后第1天的曲线下面积:一项回顾性观察研究。
Infect Dis Ther. 2024 Aug;13(8):1807-1819. doi: 10.1007/s40121-024-01004-2. Epub 2024 Jun 26.
3
Vancomycin AUC estimation using first-order pharmacokinetic methods in pediatric patients.利用一阶药代动力学方法估算儿科患者的万古霉素 AUC。
Pharmacotherapy. 2024 Apr;44(4):294-300. doi: 10.1002/phar.2916. Epub 2024 Mar 27.
4
Comparison of the mathematical equation and trapezoidal approach for 24 h area under the plasma concentration-time curve calculation in patients who received intravenous vancomycin in an acute care setting.比较在急性护理环境下接受静脉万古霉素治疗的患者中 24 小时血浆浓度时间曲线下面积计算的数学方程和梯形法。
Pharmacol Res Perspect. 2023 Feb;11(1):e01046. doi: 10.1002/prp2.1046.
5
Comparison of Bayesian-derived and first-order analytic equations for calculation of vancomycin area under the curve.用于计算万古霉素曲线下面积的贝叶斯推导方程与一阶分析方程的比较。
Pharmacotherapy. 2022 Apr;42(4):284-291. doi: 10.1002/phar.2670. Epub 2022 Feb 17.
6
Establishment of an AUC Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia.建立肾毒性的AUC阈值是迈向耐甲氧西林金黄色葡萄球菌菌血症个体化万古霉素给药的一步。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02535-16. Print 2017 May.
7
[Study on the optimization of administration regimen of vancomycin in critical patients].[危重症患者万古霉素给药方案的优化研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Feb;32(2):140-144. doi: 10.3760/cma.j.cn121430-20190905-00026.
8
Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration-Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia.甲磺酸伊马替尼的药代动力学和建立有限采样策略以估算巴勒斯坦慢性髓性白血病患者甲磺酸伊马替尼浓度-时间曲线下面积。
Eur J Drug Metab Pharmacokinet. 2024 Jan;49(1):43-55. doi: 10.1007/s13318-023-00868-y. Epub 2023 Nov 25.
9
Association between vancomycin trough concentration and area under the concentration-time curve in neonates.新生儿万古霉素谷浓度与浓度-时间曲线下面积之间的关联。
Antimicrob Agents Chemother. 2014 Nov;58(11):6454-61. doi: 10.1128/AAC.03620-14. Epub 2014 Aug 18.
10
Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia.感染源和万古霉素 AUC0-24/MICBMD 目标对耐甲氧西林金黄色葡萄球菌菌血症患者治疗失败的影响。
Clin Microbiol Infect. 2014 Dec;20(12):O1098-105. doi: 10.1111/1469-0691.12695. Epub 2014 Jul 12.

本文引用的文献

1
Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational Study.使用非梯形线性药代动力学方程表征成人住院患者万古霉素负荷剂量给药后第1天的曲线下面积:一项回顾性观察研究。
Infect Dis Ther. 2024 Aug;13(8):1807-1819. doi: 10.1007/s40121-024-01004-2. Epub 2024 Jun 26.
2
Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations.使用一级药代动力学方程预测首剂万古霉素的血浆浓度-时间曲线下面积(AUC)
Antibiotics (Basel). 2023 Mar 23;12(4):630. doi: 10.3390/antibiotics12040630.
3
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
药代动力学方程与贝叶斯指导下的万古霉素监测:药代动力学模型和模型指导的精准剂量试验模拟。
Clin Transl Sci. 2022 Apr;15(4):942-953. doi: 10.1111/cts.13210. Epub 2022 Feb 15.
4
Comparison of Bayesian-derived and first-order analytic equations for calculation of vancomycin area under the curve.用于计算万古霉素曲线下面积的贝叶斯推导方程与一阶分析方程的比较。
Pharmacotherapy. 2022 Apr;42(4):284-291. doi: 10.1002/phar.2670. Epub 2022 Feb 17.
5
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测:美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会的修订共识指南及综述
Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
6
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
7
Readiness to implement vancomycin monitoring based on area under the concentration-time curve: A cross-sectional survey of a national health consortium.基于浓度-时间曲线下面积实施万古霉素监测的意愿:一项针对全国性健康联盟的横断面调查。
Am J Health Syst Pharm. 2019 Jun 3;76(12):889-894. doi: 10.1093/ajhp/zxz070.
8
Vancomycin Area Under the Curve Dosing and Monitoring at an Academic Medical Center: Transition Strategies and Lessons Learned.学术医疗中心的万古霉素曲线下面积给药与监测:过渡策略及经验教训
J Pharm Pract. 2020 Dec;33(6):774-778. doi: 10.1177/0897190019834369. Epub 2019 Mar 10.
9
Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients.贝叶斯剂量优化软件和计算危重症患者万古霉素曲线下面积方程的回顾与验证。
Pharmacotherapy. 2018 Dec;38(12):1174-1183. doi: 10.1002/phar.2191. Epub 2018 Nov 23.
10
Making the change to area under the curve-based vancomycin dosing.改为基于曲线下面积的万古霉素给药方案。
Am J Health Syst Pharm. 2018 Dec 15;75(24):1986-1995. doi: 10.2146/ajhp180034. Epub 2018 Oct 17.